This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Sep 19;386(9999):1116-8.

doi: 10.1016/S0140-6736(15)61175-8. Epub 2015 Jul 2.

More DATA to guide sequential osteoporosis therapy

Lorenz C Hofbauer¹, Tilman D Rachner²

Affiliations

Affiliations

¹ Division of Endocrinology, Diabetes, and Bone Diseases, Technische Universität Dresden Medical Center, 01307 Dresden, Germany; Center for Regenerative Therapies Dresden, Germany. Electronic address: lorenz.hofbauer@uniklinikum-dresden.de.
² Division of Endocrinology, Diabetes, and Bone Diseases, Technische Universität Dresden Medical Center, 01307 Dresden, Germany.

PMID: 26144907
DOI: 10.1016/S0140-6736(15)61175-8

Comment

More DATA to guide sequential osteoporosis therapy

Lorenz C Hofbauer et al. Lancet. 2015.

. 2015 Sep 19;386(9999):1116-8.

doi: 10.1016/S0140-6736(15)61175-8. Epub 2015 Jul 2.

Authors

Lorenz C Hofbauer¹, Tilman D Rachner²

Affiliations

¹ Division of Endocrinology, Diabetes, and Bone Diseases, Technische Universität Dresden Medical Center, 01307 Dresden, Germany; Center for Regenerative Therapies Dresden, Germany. Electronic address: lorenz.hofbauer@uniklinikum-dresden.de.
² Division of Endocrinology, Diabetes, and Bone Diseases, Technische Universität Dresden Medical Center, 01307 Dresden, Germany.

PMID: 26144907
DOI: 10.1016/S0140-6736(15)61175-8

No abstract available

PubMed Disclaimer

Comment on

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.
Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM, Burnett-Bowie SA. Leder BZ, et al. Lancet. 2015 Sep 19;386(9999):1147-55. doi: 10.1016/S0140-6736(15)61120-5. Epub 2015 Jul 2. Lancet. 2015. PMID: 26144908 Free PMC article. Clinical Trial.

Similar articles

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.
Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM, Burnett-Bowie SA. Leder BZ, et al. Lancet. 2015 Sep 19;386(9999):1147-55. doi: 10.1016/S0140-6736(15)61120-5. Epub 2015 Jul 2. Lancet. 2015. PMID: 26144908 Free PMC article. Clinical Trial.
Osteoporosis: Teriparatide and denosumab: two drugs are better than one!
Buckland J. Buckland J. Nat Rev Rheumatol. 2013 Jul;9(7):383. doi: 10.1038/nrrheum.2013.79. Epub 2013 May 28. Nat Rev Rheumatol. 2013. PMID: 23712125 No abstract available.
Is it time to combine osteoporosis therapies?
Eastell R, Walsh JS. Eastell R, et al. Lancet. 2013 Jul 6;382(9886):5-7. doi: 10.1016/S0140-6736(13)60984-8. Epub 2013 May 15. Lancet. 2013. PMID: 23683601 Free PMC article.
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
Wensel TM, Iranikhah MM, Wilborn TW. Wensel TM, et al. Pharmacotherapy. 2011 May;31(5):510-23. doi: 10.1592/phco.31.5.510. Pharmacotherapy. 2011. PMID: 21923432 Review.
[Anti-osteoporosis drugs based on the guidelines for the Prevention and Treatment of Osteoporosis (2011 edition) ].
Ono K, Ohashi S, Tanaka S. Ono K, et al. Clin Calcium. 2014 Mar;24(3):401-6. Clin Calcium. 2014. PMID: 24576937 Review. Japanese.

See all similar articles

Cited by

Teriparatide in postmenopausal osteoporosis: uncovering novel insights into efficacy and safety compared to other treatments - a systematic review and meta-analysis.
Arthur Vithran DT, Essien AE, Rahmati M, Opoku M, Keon Yon D, López Sánchez GF, Koyanagi A, Smith L, Il Shin J, Xiao W, Liu S, Li Y. Arthur Vithran DT, et al. EFORT Open Rev. 2024 Sep 2;9(9):845-861. doi: 10.1530/EOR-23-0205. EFORT Open Rev. 2024. PMID: 39222329 Free PMC article.
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2024.
American Diabetes Association Professional Practice Committee. American Diabetes Association Professional Practice Committee. Diabetes Care. 2024 Jan 1;47(Suppl 1):S52-S76. doi: 10.2337/dc24-S004. Diabetes Care. 2024. PMID: 38078591 Review.
Iron metabolism and ferroptosis in diabetic bone loss: from mechanism to therapy.
Bao J, Yan Y, Zuo D, Zhuo Z, Sun T, Lin H, Han Z, Zhao Z, Yu H. Bao J, et al. Front Nutr. 2023 May 5;10:1178573. doi: 10.3389/fnut.2023.1178573. eCollection 2023. Front Nutr. 2023. PMID: 37215218 Free PMC article. Review.
Prediction of osteoporosis using radiomics analysis derived from single source dual energy CT.
Wang J, Zhou S, Chen S, He Y, Gao H, Yan L, Hu X, Li P, Shen H, Luo M, You T, Li J, Zhong Z, Zhang K. Wang J, et al. BMC Musculoskelet Disord. 2023 Feb 7;24(1):100. doi: 10.1186/s12891-022-06096-w. BMC Musculoskelet Disord. 2023. PMID: 36750927 Free PMC article.
Radiomics nomogram based on dual-energy spectral CT imaging to diagnose low bone mineral density.
Yao Q, Liu M, Yuan K, Xin Y, Qiu X, Zheng X, Li C, Duan S, Qin J. Yao Q, et al. BMC Musculoskelet Disord. 2022 May 6;23(1):424. doi: 10.1186/s12891-022-05389-4. BMC Musculoskelet Disord. 2022. PMID: 35524240 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science